In patients with prostate cancer, the high DHX9 expression was significantly associated with shorter disease-free survival (DFS), which may indicate the clinical relevance of DHX9 function in prostate carcinogenesis (7). This evidence concerns the gene DHX9 and Familial prostate cancer.